90 employees
LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.
2019
$310M
from 6 investors over 6 rounds
LianBio raised $310M on October 29, 2020
Investors: RA Capital Management, L.P., Perceptive Advisors, Wellington Management, Viking Global Investors, T. Rowe Price and Vida Ventures, LLC